Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 28  •  04:00PM ET
30.55
Dollar change
-1.18
Percentage change
-3.72
%
Index
RUT
P/E
-
EPS (ttm)
-1.40
Insider Own
31.47%
Shs Outstand
85.28M
Perf Week
-4.08%
Market Cap
2.62B
Forward P/E
-
EPS next Y
-0.35
Insider Trans
-7.66%
Shs Float
58.77M
Perf Month
23.73%
Enterprise Value
2.47B
PEG
-
EPS next Q
-0.19
Inst Own
56.75%
Perf Quarter
-2.11%
Income
-116.79M
P/S
14.88
EPS this Y
65.23%
Inst Trans
21.37%
Perf Half Y
-19.33%
Sales
176.03M
P/B
8.67
EPS next Y
38.46%
ROA
-
Perf YTD
4.80%
Book/sh
3.53
P/C
14.82
EPS next 5Y
-
ROE
-
52W High
41.22 -25.89%
Perf Year
-
Cash/sh
2.06
P/FCF
-
EPS past 3/5Y
5.20% -
ROIC
-36.87%
52W Low
20.13 51.76%
Perf 3Y
-
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
42.10% -
Gross Margin
76.80%
Volatility
5.39% 5.70%
Perf 5Y
-
Dividend TTM
-
EV/Sales
14.00
EPS Y/Y TTM
-
Oper. Margin
-36.39%
ATR (14)
1.71
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
5.04
Sales Y/Y TTM
-
Profit Margin
-66.35%
RSI (14)
58.67
Dividend Gr. 3/5Y
- -
Current Ratio
5.04
EPS Q/Q
-10.93%
SMA20
6.34%
Beta
-
Payout
-
Debt/Eq
0.07
Sales Q/Q
83.03%
SMA50
18.26%
Rel Volume
0.59
Prev Close
31.73
Employees
843
LT Debt/Eq
0.05
SMA200
1.34%
Avg Volume
1.61M
Price
30.55
IPO
Aug 08, 2025
Option/Short
Yes / Yes
Trades
Volume
951,863
Change
-3.72%
Date Action Analyst Rating Change Price Target Change
Jan-28-26Initiated Wells Fargo Overweight $38
Sep-02-25Initiated Stifel Buy $35
Sep-02-25Initiated Piper Sandler Overweight $38
Sep-02-25Initiated Morgan Stanley Equal-Weight $35
Sep-02-25Initiated JP Morgan Overweight $36
Sep-02-25Initiated Canaccord Genuity Buy $35
Apr-23-26 04:05PM
Apr-13-26 08:30AM
Mar-27-26 09:30AM
Mar-18-26 11:00PM
04:22PM
04:01PM Loading…
04:01PM
Mar-17-26 09:18AM
Mar-16-26 08:00AM
Feb-25-26 01:26AM
Feb-18-26 04:05PM
Feb-13-26 04:21PM
Feb-12-26 08:00AM
Jan-29-26 09:41AM
Jan-28-26 09:39AM
Jan-06-26 08:00AM
04:05PM Loading…
Jan-05-26 04:05PM
Dec-23-25 11:53PM
Dec-18-25 07:42PM
04:05PM
Dec-12-25 09:49AM
Dec-11-25 03:10AM
Nov-19-25 04:33PM
Nov-12-25 04:22PM
04:01PM
Nov-09-25 01:30PM
Nov-04-25 07:06AM
Nov-03-25 08:00AM
Oct-23-25 04:05PM
Oct-22-25 08:00AM
Sep-29-25 08:07AM
06:55PM Loading…
Sep-23-25 06:55PM
Sep-22-25 04:05PM
Sep-19-25 05:28PM
Sep-11-25 01:00AM
Sep-06-25 06:35AM
Sep-04-25 10:20AM
Sep-03-25 04:54PM
04:54PM
09:16AM
Sep-02-25 09:45AM
Aug-27-25 04:24PM
Aug-18-25 01:16PM
Aug-11-25 04:30PM
Aug-09-25 09:53AM
Aug-08-25 01:40PM
Jul-22-25 06:28PM
HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in July 2007 and is headquartered in Mountain View, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farquhar John C.M.Chief Executive OfficerApr 10 '26Sale26.7222,562602,857549,163Apr 14 05:53 PM
Farquhar John C.M.OfficerApr 10 '26Proposed Sale26.7222,562602,857Apr 10 11:03 AM
Rogers CampbellChief Medical OfficerApr 01 '26Option Exercise2.2567,017150,556145,535Apr 03 06:15 PM
Rogers CampbellChief Medical OfficerApr 01 '26Sale24.6464,5331,590,09381,002Apr 03 06:15 PM
Rogers CampbellOfficerApr 01 '26Proposed Sale24.6464,5331,589,935Apr 01 04:23 PM
Rogers CampbellChief Medical OfficerMar 19 '26Option Exercise2.2267,017148,778143,051Mar 23 06:33 PM
Rogers CampbellChief Medical OfficerMar 19 '26Sale25.6964,5331,658,03378,518Mar 23 06:33 PM
Farquhar John C.M.Chief Executive OfficerMar 18 '26Sale25.009,725243,125571,725Mar 20 06:24 PM
Rogers CampbellOfficerMar 19 '26Proposed Sale25.6964,5331,658,030Mar 19 04:23 PM
Farquhar John C.M.OfficerMar 18 '26Proposed Sale25.009,725243,125Mar 18 02:17 PM
BARABE TIMOTHY CDirectorMar 11 '26Option Exercise2.228,66719,241179,521Mar 12 07:57 PM
Farquhar John C.M.Chief Executive OfficerMar 10 '26Sale22.6612,837290,886581,450Mar 12 07:55 PM
Farquhar John C.M.OfficerMar 10 '26Proposed Sale22.6612,837290,886Mar 10 10:53 AM
Cullivan Julie ADirectorMar 05 '26Sale25.009,122228,05027,291Mar 06 08:18 PM
Cullivan Julie ADirectorMar 05 '26Proposed Sale25.009,122228,050Mar 05 02:11 PM
BARABE TIMOTHY CDirectorFeb 17 '26Option Exercise8.332,49720,800170,854Feb 19 07:14 PM
Rogers CampbellChief Medical OfficerFeb 12 '26Option Exercise5.8467,016391,398141,187Feb 17 08:07 PM
Rogers CampbellChief Medical OfficerFeb 12 '26Sale24.4965,1531,595,48676,034Feb 17 08:07 PM
Rogers CampbellOfficerFeb 12 '26Proposed Sale24.4965,1531,595,485Feb 12 04:45 PM
Farquhar John C.M.Chief Executive OfficerFeb 10 '26Sale27.4622,562619,553591,656Feb 10 08:24 PM
Farquhar John C.M.OfficerFeb 10 '26Proposed Sale27.4622,562619,557Feb 10 04:12 PM
Cullivan Julie ADirectorFeb 05 '26Sale27.328,000218,56036,413Feb 06 09:42 PM
Bain Capital Life Sciences Inv10% OwnerFeb 04 '26Sale28.052,000,00056,100,00010,448,158Feb 06 04:58 PM
Cullivan Julie ADirectorFeb 05 '26Proposed Sale27.328,000218,560Feb 05 09:58 AM
Lightcap Jeffrey CDirectorDec 16 '25Buy26.3440,0001,053,68040,000Dec 17 06:43 PM